Skip to main content
Log in

Modeling Interactions between Adrenal Suppression and T-Helper Lymphocyte Trafficking during Multiple Dosing of Methylprednisolone

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

A physiologic pharmacodynamic model was developed to jointly characterize the effects of corticosteroid treatment on adrenal suppression and T-helper cell trafficking during single and multiple dosing in asthmatic patients. Methylprednisolone (MP), cortisol, and T-helper cell concentrations obtained from a previously published study during single day and 6 days of multiple dosing MP treatment were examined. The formation and disposition kinetics of MP were described with a compartmental model. The biorhythmic profile of basal cortisol secretion rate was analyzed using a recent Fourier approach based on circadian harmonics. A three-compartment loop model was proposed to represent three major T-helper cell pools: blood, extravascular site, and lymph nodes. T-helper cell synthesis and degradation rate constants were obtained from the literature. The suppressive effects of cortisol and MP on T-helper cell concentrations were described with a joint additive inhibition function altering the cell migration rate from lymph nodes to blood. The model adequately described both plasma cortisol profiles and T-helper cells in blood after single and multiple doses of MP. The potency of MP for suppression of cortisol secretion was estimated as IC50 = 0.8 ng/ml. The biorhythmic nature of the basal T-helper cells in blood was well described as under the influence of basal circadian cortisol concentrations with IC50 = 79 ng/ml. The model fitted potency of MP for suppression of T-helper cells was IC50 = 4.6 ng/ml. The observed rebound of T-helper cells in blood can also be described by the proposed model. The rhythm and suppression of plasma cortisol and T-helper cells before and during single and multiple dose MP treatment were adequately described by these extended indirect response models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. W. L. Ford and J. L. Gowans. The traffic of lymphocytes. Semin. Hematol. 6:67–83 (1969).

    CAS  PubMed  Google Scholar 

  2. A. J. Young, J. B. Hay, and C. R. Mackay. Lymphocyte recirculation and life span in vivo. Curr. Topics Microbiol. Immunol. 184:161–173 (1993).

    CAS  Google Scholar 

  3. A. J. Young and J. B. Hay. Rapid turnover of the recirculating lymphocyte pool in vivo. Int. Immunol. 7:1607–1615 (1995).

    Article  CAS  PubMed  Google Scholar 

  4. A. K. Abbas, A. H. Lichtman, and J. S. Pober. Cellular and Molecular Immunology, W. B. Saunders, Philadfelphia, PA, 1994.

    Google Scholar 

  5. Y. Shoenfeld, Y. Gurewich, L. A. Gallant, and J. Pinkhas. Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am. J. Med. 71:773–778 (1981).

    Article  CAS  PubMed  Google Scholar 

  6. T. Miyawaki, K. Taga, T. Nagaoki, H. Seki, Y. Suzuki, and N. Taniguchi. Circadian changes of T lymphocyte subsets in human peripheral blood. Clin. Exp. Immunol. 55:618–622 (1984).

    CAS  PubMed Central  PubMed  Google Scholar 

  7. H. B. Tavadia, K. A. Fleming, P. D. Hume, and H. W. Simpson. Circadian rhythmicity of human plasma cortisol and PHA-induced lymphocyte transformation. Clin. Exp. Immunol. 22:190–193 (1975).

    CAS  PubMed Central  PubMed  Google Scholar 

  8. B. Zweiman, P. C. Atkins, P. M. Bedard, S. L. Flaschen, and R. P. Lisak. Corticosteroid effects on circulating lymphocyte subset levels in normal humans. J. Clin. Immunol. 4:151–155 (1984).

    Article  CAS  PubMed  Google Scholar 

  9. T. E. Dunn, E. A. Ludwig, R. L. Slaughter, D. S. Camara, and W. J. Jusko. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Clin. Pharmacol. Ther. 49:536–549 (1991).

    Article  CAS  PubMed  Google Scholar 

  10. L. E. Fisher, E. A. Ludwig, and W. J. Jusko. Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes. J. Pharmacokin. Biopharm. 20:319–331 (1992).

    Article  CAS  Google Scholar 

  11. N. L. Dayneka, V. Garg, and W. J. Jusko. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokin. Biopharm. 21:457–478 (1993).

    Article  CAS  Google Scholar 

  12. M. C. Braat, B. Oosterhuis, R. P. Koopmans, J. M. Meewis, and C. J. Van Boxtel. Kineticdynamic modeling of lymphocytopenia induced by the combined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone. J. Pharmacol. Exp. Ther. 262:509–515 (1992).

    CAS  PubMed  Google Scholar 

  13. E. J. Ariëns and A. M. Simonis. A molecular basis for drug action. The interaction of one or more drugs with different receptors. J. Pharm. Pharmacol. 16:289–312 (1964).

    Article  Google Scholar 

  14. M. A. Milad, E. A. Ludwig, S. Anne, E. Middleton, Jr., and W. J. Jusko. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J. Pharmacokin. Biopharm. 22:469–480 (1994).

    Article  CAS  Google Scholar 

  15. K. L. Slayter, E. A. Ludwig, K. H. Lew, E. Middleton, Jr., J. J. Ferry, and W. J. Jusko. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 59:312–321 (1996).

    Article  CAS  PubMed  Google Scholar 

  16. S. Rohatagi, A. Bye, C. Falcoz, A. E. Mackie, B. Meibohm, H. Mollmann, and H. Derendorf. Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate. J. Clin. Pharmacol. 36:938–941 (1996).

    Article  CAS  PubMed  Google Scholar 

  17. G. M. L. Meno-Tetang, R. A. Blum, K. E. Schwartz, and W. J. Jusko. Pharmacodynamic modeling of dehydroepiandrosterone (DHEA), DHEA-SO4 and cortisol suppression by prednisolone. Pharm. Res. 14:S609 (1997).

    Google Scholar 

  18. A. Chakraborty, R. A. Blum, D. L. Cutler, and W. J. Jusko. Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers. Clin. Pharmacol. Ther. 65:304–318 (1999).

    Article  CAS  PubMed  Google Scholar 

  19. W. Krzyzanski, A. Chakraborty, and W. J. Jusko. Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models. Chronobiol. Int. 17:77–93 (2000).

    Article  CAS  PubMed  Google Scholar 

  20. A. Chakraborty, W. Krzyzanski, and W. J. Jusko. Mathematical modeling of circadian cortisol concentrations using indirect response models: Comparison of several methods. J. Pharmacokin. Biopharm. 27:23–43 (1999).

    Article  CAS  Google Scholar 

  21. E. O. Field, H. B. Sharpe, K. B. Dawson, V. Andersen, S. A. Killmann, and E. Weeke. Turnover rate of normal blood lymphocytes and exchangeable pool size in man, calculated from analysis of chromosomal aberrations sustained during extracorporeal irradiation of the blood. Blood 39:39–56 (1972).

    CAS  PubMed  Google Scholar 

  22. F. Trepel. Number and distribution of lymphocytes in man. A critical analysis. Klin. Wochenschr. 52:511–515 (1974).

    Article  CAS  PubMed  Google Scholar 

  23. G. Reinecke and R. Pabst. Subsets of blood, spleen and recirculating lymphocytes in man. Clin. Exp. Immunol. 53:672–678 (1983).

    CAS  PubMed Central  PubMed  Google Scholar 

  24. M. Hellerstein, M. B. Hanley, D. Cesar, S. Siler, C. Papageorgopoulos, E. Wieder, D. Schmidt, R. Hoh, R. Neese, D. Macallan, S. Deeks, and J. M. McDune. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5:83–89 (1999).

    Article  CAS  PubMed  Google Scholar 

  25. A. N. Kong, E. A. Ludwig, R. L. Slaughter, P. M. DiStefano, J. DeMasi, E. Middleton, Jr., and W. J. Jusko. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin. Pharmacol. Ther. 46:616–628 (1989).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. W. G. Reiss, R. L. Slaughter, E. A. Ludwidg, E. Middleton, Jr., and W. J. Jusko. Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. J. Allergy Clin. Immunol. 85:1058–1066 (1990).

    Article  CAS  PubMed  Google Scholar 

  27. D. Z. D'Argenio and A. Schumitzky. A program package for simulation and parameter estimation in pharmacokinetic systems. Comput. Prog. Biomed. 9:115–134 (1979).

    Article  Google Scholar 

  28. J. J. Lima, J. Giller, J. J. Mackichan, and W. J. Jusko. Bioavailability of hydrocortisone retention enemas in normal subjects. Am. J. Gastroenterol. 73:232–237 (1980).

    CAS  PubMed  Google Scholar 

  29. E. C. Butcher and L. J. Picker. Lymphocyte homing and homeostasis. Science 272:60–66 (1996).

    Article  CAS  PubMed  Google Scholar 

  30. H. B. Stamper and J. J. Woodruff. Lymphocyte homing into lymph nodes: In vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J. Exp. Med. 144:828–833 (1976).

    Article  PubMed  Google Scholar 

  31. W. M. Kieran, V. Blank, O. le Bail, and A. Israel. Lymphocyte homing. Res. Immunol. 140:399–450 (1989).

    Article  CAS  PubMed  Google Scholar 

  32. J. Westermann and R. Pabst. Distribution of lymphocyte subsets and natural killer cells in the human body. Clin. Invest. 70:539–544 (1992).

    Article  CAS  Google Scholar 

  33. A. Sharma, W. F. Ebling, and W. J. Jusko. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. J. Pharm. Sci. 87:1577–1584 (1998).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chow, FS., Sharma, A. & Jusko, W.J. Modeling Interactions between Adrenal Suppression and T-Helper Lymphocyte Trafficking during Multiple Dosing of Methylprednisolone. J Pharmacokinet Pharmacodyn 27, 559–575 (1999). https://doi.org/10.1023/A:1020974408657

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020974408657

Navigation